Literature DB >> 16197366

Effects of angiotensin-converting-enzyme inhibitors in combination with diuretics on blood pressure and renal injury in nitric oxide-deficiency-induced hypertension in rats.

Joaquín García-Estañ1, M Clara Ortiz, Francisco O'Valle, Antonia Alcaraz, Esther G Navarro, Félix Vargas, Stefano Evangelista, Noemí M Atucha.   

Abstract

The present study investigates the effects of chronic administration of ACEIs (angiotensin-converting-enzyme inhibitors; either zofenopril or enalapril) in combination with a diruetic (hydrochlorothiazide) on BP (blood pressure) increase and renal injury induced by L-NAME (NG-nitro-L-arginine methyl ester), an inhibitor of NO (nitric oxide) synthesis. Rats were untreated or received L-NAME alone, L-NAME+zofenopril+hydrochlorothiazide or L-NAME+enalapril+hydrochlorothiazide for 8 weeks. L-NAME treatment resulted in marked elevation in BP and mortality. Treatment with either ACEI and diuretic prevented the increase in BP induced by L-NAME, reduced the death rate and improved excretory parameters. Renal injury in the L-NAME group was severe, but, in the groups treated with either ACEI and diuretic, glomerular and tubulointerstitial lesions were not observed and the intensity, number and size of vessels affected was reduced. However, the efficacy of zofenopril+diuretic was superior to that of enalapril+diuretic in reducing vascular alterations. Oxidative stress indices and the expression of NO synthase and nitrotyrosine were normalized by the treatments. In conclusion, the combined treatment of zofenopril or enalapril with hydrochlorothiazide completely prevented the development of arterial hypertension induced by L-NAME. Renal morphological and functional alterations in the hypertensive animals were also almost completely normalized, but the treatment with zofenopril+diuretic produced a more complete organ protection. The protective effect is related to an activation of endothelial NO synthase expression and to a normalization of the oxidative stress parameters due to the inhibition of angiotensin II.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16197366     DOI: 10.1042/CS20050165

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  7 in total

1.  End-organ protection in hypertension by the novel and selective Rho-kinase inhibitor, SAR407899.

Authors:  Matthias Löhn; Oliver Plettenburg; Aimo Kannt; Markus Kohlmann; Armin Hofmeister; Dieter Kadereit; Peter Monecke; Alexander Schiffer; Anke Schulte; Hartmut Ruetten; Yuri Ivashchenko
Journal:  World J Cardiol       Date:  2015-01-26

Review 2.  Zofenopril plus hydrochlorothiazide: Combination therapy for the treatment of mild to moderate hypertension.

Authors:  Alberto Zanchetti; Gianfranco Parati; Ettore Malacco
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 3.  Fixed combination of zofenopril plus hydrochlorothiazide in the management of hypertension: a review of available data.

Authors:  Claudio Borghi; Arrigo F G Cicero
Journal:  Vasc Health Risk Manag       Date:  2006

Review 4.  Efficacy of Zofenopril vs. Irbesartan in Combination with a Thiazide Diuretic in Hypertensive Patients with Multiple Risk Factors not Controlled by a Previous Monotherapy: A Review of the Double-Blind, Randomized "Z" Studies.

Authors:  Stefano Omboni; Ettore Malacco; Claudio Napoli; Pietro Amedeo Modesti; Athanasios Manolis; Gianfranco Parati; Enrico Agabiti-Rosei; Claudio Borghi
Journal:  Adv Ther       Date:  2017-03-04       Impact factor: 3.845

5.  Beneficial Effects of Different Flavonoids on Vascular and Renal Function in L-NAME Hypertensive Rats.

Authors:  M Dolores Paredes; Paola Romecín; Noemí M Atucha; Francisco O'Valle; Julián Castillo; M Clara Ortiz; Joaquín García-Estañ
Journal:  Nutrients       Date:  2018-04-13       Impact factor: 5.717

6.  Moderate Effect of Flavonoids on Vascular and Renal Function in Spontaneously Hypertensive Rats.

Authors:  María D Paredes; Paola Romecín; Noemí M Atucha; Francisco O'Valle; Julián Castillo; María Clara Ortiz; Joaquín García-Estañ
Journal:  Nutrients       Date:  2018-08-16       Impact factor: 5.717

7.  Efficacy of zofenopril in combination with thiazide diuretics in patients with acute myocardial infarction: a pooled individual data analysis of four randomized, double-blind, controlled, prospective studies.

Authors:  Claudio Borghi; Stefano Omboni; Giorgio Reggiardo; Stefano Bacchelli; Daniela Degli Esposti; Ettore Ambrosioni
Journal:  Ther Clin Risk Manag       Date:  2018-07-09       Impact factor: 2.423

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.